Clinical Trial: The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to determine the effectiveness of intravitreal autologous platelet concentrate (APC) injection during the surgery for refractory macular holes.

Detailed Summary:
Sponsor: Samsung Medical Center

Current Primary Outcome: macular hole closure [ Time Frame: 6 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

• best-corrected visual acuity [ Time Frame: 6 months ]
• metamorphopsia score [ Time Frame: 6 months ]
• safety outcome [ Time Frame: 6 months ]
  frequency and severity of ocular adverse event

Original Secondary Outcome: Same as current

Information By: Samsung Medical Center

Dates:
Date Received: March 5, 2014
Date Started: December 2013
Date Completion:
Last Updated: March 6, 2014
Last Verified: March 2014